PPIs have also demonstrated a positive effect on glycemic control in a model of type 2 diabetes—Psammomys obesus. In this study PPI lansoprazole had significant glucose-lowering effects in an animal model of type 2 diabetes, an effect that is most likely mediated through an increase in endogenous gastrin levels.